Showing 401-410 of 2527 results for "".
UGH Syndrome: When Implants Fight Back
https://modernod.com/topics/patient-care/ugh-syndrome-when-implants-fight-back/48748/Mechanical irritation from an IOL or other intraocular device can have serious consequences.New Data Reveal Diabetes Affects Corneal Thickness
https://modernod.com/articles/significant-findings/new-data-reveal-diabetes-affects-corneal-thickness/48883/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuRetina Challenges, Rewards, and Career Opportunities
https://modernod.com/topics/retina/retina-challenges-rewards-and-career-opportunities/39024/Highlights from a recent YoungOD Connect mentoring session.Lickety-Split Retina
https://modernod.com/topics/retina/lickety-split-retina/38981/This case highlights the importance of pinpointing the cause of decreased vision, especially in younger patients.Industry Insider
https://modernod.com/topics/presbyopia/industry-insider-1/38976/Therapeutics in the 2025 Pipeline
https://modernod.com/topics/contact-lenses/therapeutics-in-the-2025-pipeline/38957/Get familiar with exciting new treatments coming to market this year.Spiculated Speculation: When RP and Glaucoma Collide
https://modernod.com/topics/glaucoma/spiculated-speculation-when-rp-and-glaucoma-collide/38952/How to differentiate between the two to arrive at the correct diagnosis.2024 in Review: FDA Approvals and Product Launches
https://modernod.com/mod-issues/2025-jan-feb/2024-in-review-fda-approvals-and-product-launches/38933/An overview of new optometric medications and technologies to know about.It’s Time to Knock Glaucoma Down a Few Pegs
https://modernod.com/topics/glaucoma/its-time-to-knock-glaucoma-down-a-few-pegs/38917/What’s Trending in Presbyopia CL Prescribing?
https://modernod.com/articles/significant-findings/whats-trending-in-presbyopia-cl-prescribing/37819/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat